Abstract
Photodynamic therapy (PDT) has been reported as an effective method of treatment in patients with subfoveal choroidal neovascularisation (SFCNV) caused by age-related macular degeneration (AMD), presumed ocular histoplasmosis syndrome (POHS) and myopic maculopathy (No Authors, 1999; Bressler, 2001; No Authors, 2001). The basic mechanism of PDT is the light activation of photosensitizing agent based on its absorption profile. PDT involves two crucial steps;
I.The intravenous injection of photosensitizing drug (verteporfin)
II.The delivery of 689 nm. wavelength laser to the target tissue which is SFCNV
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bressler, N.M., 2001, Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2., Arch. Ophthalmol., Feb; 119(2):198-207.
Gass, J.D.M., 1997, Stereoscopic Atlas of Macular Diseases Diagnosis and Treatment, Mosby, St. Louis
Gelisken, F., Inhoffen, W., Partsch, M., Schneider, U., and Kreissig, I., 2001, Retinal pigment epithelialz tearafter photodynamic therapy for choroidal neovascularization, Am. J. Ophthalmol., Apr; 131(4):518-20.
Hunt, D.W.C., Chan, A.H., and Levy, J.G., 1998, Immunological aspects of photodynamic therapy, Photodynamics News 1(3):2-4.
Korte, G.E., Reppucci, V., and Henkind, P., 1984, RPE destruction causes choriocapillary atrophy, Invest. Ophthalmol. Vis. Set., Oct; 25(10):1135-45.
Michels, S., Barbazetto, I., and Schmidt-Erfurth, U., 2000, Choroidal changes after photodynamic therapy (PDT). A two-year follow-up study of 38 patients[Article in German], Klin. Monatsbi. Augenheilkd., Aug; 217(2):94-9.
Michels, S., Barbazetto, I., and Schmidt-Erfurth, U., 2002, Changes in neovascular membranes and normal choroid blood vessels after multiple photodynamic therapy treatments [Article in German], Ophthalmologe, Feb; 99(2):96-100.
No Authors Listed, 1999, Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group, Arch. Ophthalmol., Oct; 117(10):1329-45.
No Authors Listed, 2001, Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1., Ophthalmology, May; 108(5):841-52.
Pece, A., Introini, U., Bottoni, F., and Brancato, R., 2001, Acute retinal pigment epithelial tear after photodynamic therapy, Retina., 21(6):661-5.
Rogers, A.H., Martidis, A., Greenberg, P.B., and Puliafito, C.A., 2002, Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization, Am. J. Ophthalmol., Oct; 134(4):56676.
Schmidt-Erfurth, U., and Hasan, T., 2000, Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration, Surv. Ophthalmol., Nov-Dec; 45(3):195-214.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this paper
Cite this paper
Durlu, Y.K. (2003). Retinal and Choroidal Alterations Following Photodynamic Therapy. In: LaVail, M.M., Hollyfield, J.G., Anderson, R.E. (eds) Retinal Degenerations. Advances in Experimental Medicine and Biology, vol 533. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0067-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0067-4_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4909-9
Online ISBN: 978-1-4615-0067-4
eBook Packages: Springer Book Archive